Vanguard Global Advisers »

BioMarin Pharmaceutical shares owned by Vanguard Global Advisers

Quarter-by-quarter ownership of BioMarin Pharmaceutical (BMRN) shares owned by Vanguard Global Advisers from 13F filings

Historical chart of Vanguard Global Advisers investment in BioMarin Pharmaceutical

Tip: Access up to 7 years of quarterly data

All positions including BioMarin Pharmaceutical held by Vanguard Global Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in BioMarin Pharmaceutical by Vanguard Global Advisers

Quarter filed Position value Share count Share price at filing
2026-03-31 $5.5M 98k 56.49

More positions owned by Vanguard Global Advisers

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Index Fds Total Stk Mkt (VTI)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
Vanguard Specialized Funds Div App Etf (VIG)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
JPMorgan Chase & Co. (JPM)

View all positions for Vanguard Global Advisers

Top funds holding BioMarin Pharmaceutical

BlackRock
Vanguard Group
Dodge & Cox
PRIMECAP Management Company
Vanguard Capital Management
Vanguard Portfolio Management
AQR Capital Management
State Street Corporation
Viking Global Investors
Citadel Advisors
Geode Capital Management
Dimensional Fund Advisors
Vestal Point Capital
Capital Research Global Investors
Millennium Management

View all funds holding BioMarin Pharmaceutical